Editor’s Letter
Latest features in GaBI Journal, 2019, Issue 3
Patients, their families and providers are facing increasing pressures related to the rapidly expanding global inequality which affects access to all components of a long, healthy, productive life including water,… Read More »
Unmet potential of Generics and Biosimilars to reduce healthcare costs
The high cost of pharmaceuticals has been gaining increasing attention as a threat to both healthcare systems and patients’ access to care globally. This GaBI issue contains articles focusing on… Read More »
Editor’s introduction to the initial issue of the eighth volume of GaBI Journal
This issue contains important information and manuscripts, but the small number of original papers illustrates the challenge the GaBI Journal (as well as many other legitimate journals) is having attracting… Read More »
Fourth and final issue of GaBI Journal’s seventh volume
Globalization of the world’s economy has clearly created both major advances and ongoing challenges including in the pharmaceutical industry. Naming of pharmaceuticals might seem to be an uninteresting topic to… Read More »
Latest features in GaBI Journal, 2018, Issue 3
This third issue of GaBI Journal in 2018 contains manuscripts which discuss a number of important, post-marketing, ‘real world’ generic and biosimilar medicinal product issues. In a Commentary, Pitts and… Read More »
What to look forward to in GaBI Journal, 2018, Issue 2
The second issue of the 2018 GaBI Journal volume is being published at a time of increasing uncertainty concerning trade, tariffs, regulations as well as international and even inter-ally co-operation.… Read More »
Editor’s introduction to the initial issue of the seventh volume of GaBI Journal
There are many frustrating differences between reality and what is possible in every aspect of life, including politics, economics, science and health. This issue begins with a Commentary by Adjunct… Read More »
Fourth and final issue of GaBI Journal’s sixth volume
Change is inevitable but often resisted, including or even especially in medicine. Hand washing is still neglected 170 years after Semmelweis’ work, misuse of antibiotics persists 72 years after Fleming… Read More »
What to look forward to in GaBI Journal, 2017, Issue 2
The use both generics and biosimilars offers the potential to increase availability of medicines through decreases in cost that should occur when an expensive product (drug) loses patent protection and… Read More »
Editor’s introduction to the initial issue of the sixth volume of GaBI Journal
This first issue of 2017 includes a range of manuscripts of interest to readers. A Letter to the Editor from Professor Mohamed Izham Mohamed Ibrahim and Nada Moustafa Abdel Rida… Read More »